{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:37:38Z","timestamp":1794857858920,"version":"4.9.1"},"reference-count":182,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.freeradbiomed.2016.06.023","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T13:04:46Z","timestamp":1466946286000},"page":"153-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":264,"special_numbering":"C","title":["PPAR\u03b3 as a therapeutic target to rescue mitochondrial function in neurological disease"],"prefix":"10.1016","volume":"100","author":[{"given":"Juan Carlos","family":"Corona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Duchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.reprotox.2008.10.001","article-title":"Review of the expression of peroxisome proliferator-activated receptors alpha (PPAR alpha), beta (PPAR beta), and gamma (PPAR gamma) in rodent and human development","volume":"27","author":"Abbott","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/13894501113149990199","article-title":"The first approved agent in the Glitazar's Class: Saroglitazar","volume":"15","author":"Agrawal","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainres.2009.03.040","article-title":"Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat","volume":"1271","author":"Allahtavakoli","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib4","doi-asserted-by":"crossref","first-page":"18625","DOI":"10.1074\/jbc.M702538200","article-title":"Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma","volume":"282","author":"Ambrosio","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature13887","article-title":"An ERK\/Cdk5 axis controls the diabetogenic actions of PPARgamma","volume":"517","author":"Banks","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/384641a0","article-title":"The CBP co-activator is a histone acetyltransferase","volume":"384","author":"Bannister","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","article-title":"PPAR gamma is required for placental, cardiac, and adipose tissue development","volume":"4","author":"Barak","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI200318012","article-title":"Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma","volume":"112","author":"Bell-Parikh","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib9","doi-asserted-by":"crossref","first-page":"35899","DOI":"10.1074\/jbc.M112.366419","article-title":"The peroxisome proliferator-activated receptor gamma (PPARgamma) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis","volume":"287","author":"Benedusi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu. Rev. Med"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/138161206780574579","article-title":"PPAR-gamma agonists as regulators of microglial activation and brain inflammation","volume":"12","author":"Bernardo","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib12","doi-asserted-by":"crossref","first-page":"864140","DOI":"10.1155\/2008\/864140","article-title":"Regulation of glial cell functions by PPAR-gamma natural and synthetic agonists","volume":"2008","author":"Bernardo","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.numecd.2009.04.011","article-title":"Peroxisome proliferator-activated receptors and angiogenesis","volume":"19","author":"Biscetti","year":"2009","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib14","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1210\/jc.2005-1024","article-title":"Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro","volume":"90","author":"Bogacka","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib15","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2337\/diabetes.54.5.1392","article-title":"Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo","volume":"54","author":"Bogacka","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","article-title":"Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat","volume":"137","author":"Braissant","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib17","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1210\/endo.139.6.6049","article-title":"Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development","volume":"139","author":"Braissant","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib18","doi-asserted-by":"crossref","first-page":"e1001854","DOI":"10.1371\/journal.pmed.1001854","article-title":"Glitazone treatment and incidence of Parkinson's Disease among people with diabetes: a retrospective cohort study","volume":"12","author":"Brauer","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib19","doi-asserted-by":"crossref","first-page":"658520","DOI":"10.1155\/2008\/658520","article-title":"PPAR regulation of inflammatory signaling in CNS diseases","volume":"2008","author":"Bright","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib20","first-page":"3930","article-title":"Nuclear receptors PPARbeta\/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart","volume":"117","author":"Burkart","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1023\/B:NERE.0000014834.06405.af","article-title":"Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress","volume":"29","author":"Canevari","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuroscience.2011.07.046","article-title":"Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model","volume":"194","author":"Carta","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07413","article-title":"Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA","volume":"456","author":"Chandra","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/83336","article-title":"PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation","volume":"7","author":"Chawla","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib25","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/endo.135.2.8033830","article-title":"Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation","volume":"135","author":"Chawla","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12035-012-8259-8","article-title":"Peroxisome proliferator-activated receptor gamma (PPAR-gamma) and neurodegenerative disorders","volume":"46","author":"Chen","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib27","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddq322","article-title":"Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma","volume":"19","author":"Chiang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.yexcr.2015.09.005","article-title":"Rosiglitazone activation of PPARgamma-dependent signaling is neuroprotective in mutant huntingtin expressing cells","volume":"338","author":"Chiang","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.08.016","article-title":"PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease","volume":"45","author":"Chiang","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature09291","article-title":"Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5","volume":"466","author":"Choi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib31","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1172\/JCI24130","article-title":"PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1","volume":"115","author":"Chui","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jpain.2008.02.002","article-title":"Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats","volume":"9","author":"Churi","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib33","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1152\/ajpendo.00424.2003","article-title":"Identification of a novel mitochondrial protein (\"mitoNEET\") cross-linked specifically by a thiazolidinedione photoprobe","volume":"286","author":"Colca","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1753944708090924","article-title":"PPARs as new therapeutic targets for the treatment of cerebral ischemia\/reperfusion injury","volume":"2","author":"Collino","year":"2008","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.expneurol.2013.12.012","article-title":"PPARgamma activation rescues mitochondrial function from inhibition of complex I and loss of PINK1","volume":"253","author":"Corona","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib36","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.neuropharm.2006.12.008","article-title":"Ca2+-permeable AMPA receptors and intracellular Ca2+ determine motoneuron vulnerability in rat spinal cord in vivo","volume":"52","author":"Corona","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib37","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1517\/14728222.11.11.1415","article-title":"Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis","volume":"11","author":"Corona","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib38","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1046\/j.1471-4159.1998.70041366.x","article-title":"Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system","volume":"70","author":"Cullingford","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib39","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1074\/jbc.M100878200","article-title":"Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists","volume":"276","author":"Davies","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2015.07.014","article-title":"Peroxisome proliferator activated receptor-gamma agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: effects on mitochondrial functions and differentiation","volume":"271","author":"De Nuccio","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.1690453","article-title":"Peroxisome proliferator-activated receptors in inflammation control","volume":"169","author":"Delerive","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib42","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1074\/jbc.M208132200","article-title":"Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes","volume":"278","author":"Dello Russo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib43","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/me.2004-0088","article-title":"Be fit or be sick: peroxisome proliferator-activated receptors are down the road","volume":"18","author":"Desvergne","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib44","first-page":"649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib45","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1523\/JNEUROSCI.5045-09.2010","article-title":"A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons","volume":"30","author":"Dill","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib46","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/MCB.17.4.2166","article-title":"Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors","volume":"17","author":"DiRenzo","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib47","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015008","article-title":"Mitochondrial biogenesis through activation of nuclear signaling proteins","volume":"5","author":"Dominy","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib48","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0092-8674(92)90031-7","article-title":"Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors","volume":"68","author":"Dreyer","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00424-012-1112-0","article-title":"Mitochondria, calcium-dependent neuronal death and neurodegenerative disease","volume":"464","author":"Duchen","year":"2012","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib50","doi-asserted-by":"crossref","first-page":"e37885","DOI":"10.1371\/journal.pone.0037885","article-title":"A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis","volume":"7","author":"Dupuis","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib51","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jphp.12445","article-title":"In-vivo antioxidant and anti-inflammatory activity of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists in animal model of bronchial asthma","volume":"67","author":"El-Naa","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib52","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1210\/endo.142.10.8458","article-title":"Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding","volume":"142","author":"Escher","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib53","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity","volume":"10","author":"Evans","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib54","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ana.10206","article-title":"Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis","volume":"51","author":"Feinstein","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib55","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib56","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1073\/pnas.0702228104","article-title":"Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis","volume":"104","author":"Forte","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib57","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrneurol.2012.200","article-title":"Neuroprotection and repair in multiple sclerosis","volume":"8","author":"Franklin","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib58","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1074\/jbc.274.7.3970","article-title":"Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene","volume":"274","author":"Frohnert","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib59","doi-asserted-by":"crossref","first-page":"37006","DOI":"10.1074\/jbc.M700447200","article-title":"Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis","volume":"282","author":"Fuenzalida","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib60","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.npp.1301252","article-title":"Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats","volume":"32","author":"Garcia-Bueno","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib61","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.biopsych.2005.01.007","article-title":"Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats","volume":"57","author":"Garcia-Bueno","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib62","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/mds.23711","article-title":"Could thiazolidinediones increase the risk of heart failure in Friedreich's ataxia patients?","volume":"26","author":"Garcia-Gimenez","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2010.229","article-title":"A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease","volume":"68","author":"Geldmacher","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib64","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.1074\/jbc.274.12.7681","article-title":"p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively","volume":"274","author":"Gelman","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib65","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1124\/mol.106.033845","article-title":"The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells","volume":"71","author":"Ghosh","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib66","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/1389450115666140115113734","article-title":"The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates?","volume":"15","author":"Gil-Mohapel","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000318845","article-title":"Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study","volume":"30","author":"Gold","year":"2010","journal-title":"Dement Geriatr. Cogn. Disord."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib68","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nm780","article-title":"A futile metabolic cycle activated in adipocytes by antidiabetic agents","volume":"8","author":"Guan","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib69","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nbd.2015.09.008","article-title":"Mitochondrial dynamics and quality control in Huntington's disease","volume":"90","author":"Guedes-Dias","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib70","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.pain.2013.04.039","article-title":"Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates inflammatory pain through the induction of heme oxygenase-1 in macrophages","volume":"154","author":"Hasegawa-Moriyama","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib71","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbrc.2012.08.039","article-title":"Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization","volume":"426","author":"Hasegawa-Moriyama","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib72","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","article-title":"Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice","volume":"128","author":"Heneka","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib73","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1073\/pnas.0503291102","article-title":"Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase","volume":"102","author":"Hibuse","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib74","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1471-4159.2006.04327.x","article-title":"Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system","volume":"100","author":"Hunter","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yexcr.2004.09.032","article-title":"Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling","volume":"304","author":"Inestrosa","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib76","first-page":"8","article-title":"Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial","volume":"14","author":"Investigators. NETiPDN-PF-Z","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib77","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib78","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2052-8426-2-26","article-title":"Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation","volume":"2","author":"Jaiswal","year":"2014","journal-title":"Mol. Cell Ther."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib79","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/jnc.12190","article-title":"Neuroprotective effects of PPAR-gamma agonist rosiglitazone in N171-82Q mouse model of Huntington's disease","volume":"125","author":"Jin","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib80","doi-asserted-by":"crossref","first-page":"e30406","DOI":"10.1371\/journal.pone.0030406","article-title":"Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARgamma","volume":"7","author":"Jin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib81","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/hmg\/ddu587","article-title":"PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43","volume":"24","author":"Joardar","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib82","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/hmg\/ddr541","article-title":"Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease","volume":"21","author":"Johri","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib83","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2005.11.177","article-title":"Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity","volume":"340","author":"Jung","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib84","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2006.11.020","article-title":"Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production","volume":"253","author":"Jung","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib85","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1073\/pnas.0407510102","article-title":"Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9","volume":"102","author":"Kawakami","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib86","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.10.007","article-title":"Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis","volume":"191","author":"Kiaei","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib87","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/mend.11.6.0007","article-title":"Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay","volume":"11","author":"Krey","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib88","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7812\/TPP\/09-052","article-title":"Thiazolidinediones: a 2010 perspective","volume":"14","author":"Krishnaswami","year":"2010","journal-title":"Perm. J."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib89","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbr.2008.10.010","article-title":"Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease","volume":"197","author":"Kumar","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib90","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.phrs.2012.02.008","article-title":"Differential susceptibility to the PPAR-gamma agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease","volume":"65","author":"Laloux","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib91","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroscience.2015.04.026","article-title":"Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARgamma agonist in vitro and in MPTP-treated mice","volume":"302","author":"Lecca","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib92","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.0511253103","article-title":"PPARdelta regulates glucose metabolism and insulin sensitivity","volume":"103","author":"Lee","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib93","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.toxlet.2012.07.016","article-title":"Rosiglitazone, a PPAR-gamma agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats","volume":"213","author":"Lee","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib94","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.taap.2014.04.021","article-title":"Rosiglitazone inhibits chlorpyrifos-induced apoptosis via modulation of the oxidative stress and inflammatory response in SH-SY5Y cells","volume":"278","author":"Lee","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib95","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","article-title":"Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs","volume":"272","author":"Lehmann","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib96","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib97","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2004.11.043","article-title":"Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP","volume":"120","author":"Lin","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib98","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1074\/jbc.M110.138115","article-title":"Role of peroxisome proliferator-activated receptor {delta}\/{beta} in hepatic metabolic regulation","volume":"286","author":"Liu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib99","doi-asserted-by":"crossref","first-page":"a009357","DOI":"10.1101\/cshperspect.a009357","article-title":"The role of autophagy in Parkinson's disease","volume":"2","author":"Lynch-Day","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1254\/jphs.08207FP","article-title":"Pioglitazone attenuates tactile allodynia and thermal hyperalgesia in mice subjected to peripheral nerve injury","volume":"108","author":"Maeda","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib101","doi-asserted-by":"crossref","first-page":"10117","DOI":"10.1523\/JNEUROSCI.5268-11.2012","article-title":"Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease","volume":"32","author":"Mandrekar-Colucci","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib102","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12311-008-0087-z","article-title":"PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy","volume":"8","author":"Marmolino","year":"2009","journal-title":"Cerebellum"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib103","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0092-8674(02)00641-4","article-title":"Combinatorial control of gene expression by nuclear receptors and coregulators","volume":"108","author":"McKenna","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib104","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1210\/endo.143.7.8892","article-title":"Minireview: nuclear receptor coactivators--an update","volume":"143","author":"McKenna","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neulet.2011.08.033","article-title":"Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury","volume":"503","author":"Meng","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib106","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib107","first-page":"105","article-title":"PPAR expression and function during vertebrate development","volume":"46","author":"Michalik","year":"2002","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib108","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.neuint.2009.05.001","article-title":"PPARgamma stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss","volume":"55","author":"Miglio","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS","volume":"123","author":"Moreno","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuropharm.2009.10.008","article-title":"Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema","volume":"58","author":"Morgenweck","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib111","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuropharm.2013.01.020","article-title":"PPARgamma activation blocks development and reduces established neuropathic pain in rats","volume":"70","author":"Morgenweck","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib112","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainresbull.2011.03.011","article-title":"Protective effect of pioglitazone, a PPARgamma ligand, in a 3 nitropropionic acid model of Huntington's disease","volume":"85","author":"Napolitano","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib113","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1523\/JNEUROSCI.3413-13.2014","article-title":"Cognitive enhancing treatment with a PPARgamma agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice","volume":"34","author":"Nenov","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib114","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1523\/JNEUROSCI.3348-08.2008","article-title":"Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist","volume":"28","author":"Nicolakakis","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1471-4159.2001.00039.x","article-title":"Survival activity of troglitazone in rat motoneurones","volume":"76","author":"Nishijima","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib116","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1182\/blood-2002-12-3944","article-title":"A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation","volume":"102","author":"Nishikata","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib117","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","article-title":"The transcriptional coactivators p300 and CBP are histone acetyltransferases","volume":"87","author":"Ogryzko","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib118","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.270.5240.1354","article-title":"Sequence and characterization of a coactivator for the steroid hormone receptor superfamily","volume":"270","author":"Onate","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib119","doi-asserted-by":"crossref","first-page":"14342","DOI":"10.1073\/pnas.0707189104","article-title":"MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone","volume":"104","author":"Paddock","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib120","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.yexcr.2004.03.034","article-title":"Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway","volume":"297","author":"Park","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib121","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.106.113472","article-title":"Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats","volume":"320","author":"Park","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib122","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/01.HYP.21.6.1020","article-title":"Effects of ciglitazone on blood pressure and intracellular calcium metabolism","volume":"21","author":"Pershadsingh","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib123","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-gamma agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib124","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.semcdb.2012.01.003","article-title":"PPARs: fatty acid sensors controlling metabolism","volume":"23","author":"Poulsen","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.freeradbiomed.2016.06.023_bib125","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/sj.ijo.0802905","article-title":"Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha","volume":"29","author":"Puigserver","year":"2005","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib126","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator","volume":"24","author":"Puigserver","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib127","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis","volume":"92","author":"Puigserver","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib128","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1074\/jbc.M804291200","article-title":"Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease","volume":"283","author":"Quintanilla","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib129","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib131","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbr.2010.08.002","article-title":"Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status","volume":"216","author":"Rodriguez-Rivera","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib132","doi-asserted-by":"crossref","first-page":"179454","DOI":"10.1155\/2011\/179454","article-title":"Rosiglitazone induces mitochondrial biogenesis in differentiated murine 3T3-L1 and C3H\/10T1\/2 adipocytes","volume":"2011","author":"Rong","year":"2011","journal-title":"PPAR Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib133","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1097-2765(00)80211-7","article-title":"PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro","volume":"4","author":"Rosen","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib134","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.cellbio.16.1.145","article-title":"Molecular regulation of adipogenesis","volume":"16","author":"Rosen","year":"2000","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib135","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1101\/gad.14.11.1293","article-title":"Transcriptional regulation of adipogenesis","volume":"14","author":"Rosen","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib136","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbalip.2007.02.003","article-title":"Safety issues and prospects for future generations of PPAR modulators","volume":"1771","author":"Rubenstrunk","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib137","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/hmg\/ddm110","article-title":"Mutation of SOD1 in ALS: a gain of a loss of function","volume":"16","author":"Sau","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib138","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib139","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1002\/j.1460-2075.1996.tb00918.x","article-title":"PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene","volume":"15","author":"Schoonjans","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib140","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1073\/pnas.0408384102","article-title":"Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand","volume":"102","author":"Schopfer","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib141","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1523\/JNEUROSCI.2038-05.2005","article-title":"The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice","volume":"25","author":"Schutz","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib142","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cmet.2007.06.001","article-title":"Transcriptional control of brown fat determination by PRDM16","volume":"6","author":"Seale","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib143","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","article-title":"PPAR gamma and human metabolic disease","volume":"116","author":"Semple","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib144","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2014.12.027","article-title":"Neuroinflammation and neuronal autophagic death were suppressed via Rosiglitazone treatment: new evidence on neuroprotection in a rat model of global cerebral ischemia","volume":"349","author":"Shao","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1440-1789.2008.00890.x","article-title":"Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis","volume":"28","author":"Shibata","year":"2008","journal-title":"Neuropathology"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib146","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib147","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2007-11108","article-title":"Rosiglitazone induces mitochondrial biogenesis in mouse brain","volume":"11","author":"Strum","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib148","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/mds.25095","article-title":"Neuronal vulnerability, pathogenesis, and Parkinson's disease","volume":"28","author":"Sulzer","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib149","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuroscience.2004.10.021","article-title":"Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia","volume":"130","author":"Sundararajan","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib150","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1179\/1743132813Y.0000000305","article-title":"Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates","volume":"36","author":"Swanson","year":"2014","journal-title":"Neurol. Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib151","doi-asserted-by":"crossref","first-page":"582809","DOI":"10.1155\/2013\/582809","article-title":"Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- gamma Agonist against MPTP","volume":"2013","author":"Swanson","year":"2013","journal-title":"PPAR Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib152","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-8-91","article-title":"The PPAR-gamma agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys","volume":"8","author":"Swanson","year":"2011","journal-title":"J. Neuroinflamm."},{"issue":"272\u2013285","key":"10.1016\/j.freeradbiomed.2016.06.023_bib153","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/mp.2010.9","article-title":"Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe\/PSEN1DeltaE9 mouse model of Alzheimer's disease","volume":"15","author":"Toledo","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib154","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib155","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","article-title":"Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor","volume":"79","author":"Tontonoz","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib156","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0959-437X(95)80025-5","article-title":"Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma","volume":"5","author":"Tontonoz","year":"1995","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib157","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPARgamma","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib158","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.biochi.2003.11.010","article-title":"Regulation of glyceroneogenesis and phosphoenolpyruvate carboxykinase by fatty acids, retinoic acids and thiazolidinediones: potential relevance to type 2 diabetes","volume":"85","author":"Tordjman","year":"2003","journal-title":"Biochimie"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib159","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-2094-11-28","article-title":"Suppression of neuroinflammation in forebrain-specific Cdk5 conditional knockout mice by PPARgamma agonist improves neuronal loss and early lethality","volume":"11","author":"Utreras","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib160","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"1812","author":"Varga","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib161","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1460-9568.2006.05037.x","article-title":"Altered PPARgamma expression and activation after transient focal ischemia in rats","volume":"24","author":"Victor","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib162","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1172\/JCI119424","article-title":"Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids","volume":"99","author":"Vidal-Puig","year":"1997","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib163","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/CS20080195","article-title":"PPARgamma and its ligands: therapeutic implications in cardiovascular disease","volume":"116","author":"Villacorta","year":"2009","journal-title":"Clin. Sci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib164","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.tiv.2011.02.004","article-title":"Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte","volume":"25","author":"Wang","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib165","doi-asserted-by":"crossref","first-page":"31781","DOI":"10.1074\/jbc.M204279200","article-title":"Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival","volume":"277","author":"Wang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib166","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1074\/jbc.M115.700385","article-title":"Selective inhibition of the mitochondrial permeability transition pore protects against neurodegeneration in experimental multiple sclerosis","volume":"291","author":"Warne","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib167","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1073\/pnas.0701078104","article-title":"MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity","volume":"104","author":"Wiley","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib168","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.biochem.70.1.341","article-title":"Peroxisome proliferator-activated receptor gamma and metabolic disease","volume":"70","author":"Willson","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib169","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1172\/JCI21752","article-title":"Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone","volume":"114","author":"Wilson-Fritch","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib170","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/clpt.2011.43","article-title":"Rosiglitazone and the risk of adverse cardiovascular outcomes","volume":"89","author":"Winterstein","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib171","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cmet.2006.01.001","article-title":"Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride\/VLDL secretion","volume":"3","author":"Wolfrum","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib172","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jcp.21730","article-title":"Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins","volume":"220","author":"Wu","year":"2009","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib173","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrm2335","article-title":"Lipid signalling in disease","volume":"9","author":"Wymann","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib174","doi-asserted-by":"crossref","first-page":"e55080","DOI":"10.1371\/journal.pone.0055080","article-title":"Peroxisome proliferator-activated receptor-gamma agonist 15d-prostaglandin J2 mediates neuronal autophagy after cerebral ischemia-reperfusion injury","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib175","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1523\/JNEUROSCI.1569-12.2012","article-title":"PPARgamma\/RXRalpha-induced and CD36-mediated microglial amyloid-beta phagocytosis results in cognitive improvement in amyloid precursor protein\/presenilin 1 mice","volume":"32","author":"Yamanaka","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib176","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1073\/pnas.93.12.5709","article-title":"A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide","volume":"93","author":"Yim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib177","doi-asserted-by":"crossref","first-page":"32696","DOI":"10.1155\/2007\/32696","article-title":"Selective modulators of PPAR-gamma activity: molecular aspects related to obesity and side-effects","volume":"2007","author":"Zhang","year":"2007","journal-title":"PPAR Res."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib178","doi-asserted-by":"crossref","first-page":"H2187","DOI":"10.1152\/ajpheart.00937.2005","article-title":"PPAR-alpha activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats","volume":"290","author":"Zhao","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib179","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1523\/JNEUROSCI.5857-08.2009","article-title":"Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia","volume":"29","author":"Zhao","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib180","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.jcbfm.9600233","article-title":"15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats","volume":"26","author":"Zhao","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib181","first-page":"185","article-title":"Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma","volume":"6","author":"Zhu","year":"1996","journal-title":"Gene Expr."},{"key":"10.1016\/j.freeradbiomed.2016.06.023_bib182","doi-asserted-by":"crossref","first-page":"e64019","DOI":"10.1371\/journal.pone.0064019","article-title":"Peroxisome proliferator-activated receptor (PPAR) gamma and PPARalpha agonists modulate mitochondrial fusion-fission dynamics: relevance to reactive oxygen species (ROS)-related neurodegenerative disorders?","volume":"8","author":"Zolezzi","year":"2013","journal-title":"PLoS One"}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916303112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916303112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:37:36Z","timestamp":1760204256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584916303112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":182,"alternative-id":["S0891584916303112"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.06.023","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR\u03b3 as a therapeutic target to rescue mitochondrial function in neurological disease","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}